ON-DEMAND Webinar

Comprehensive Analytical Strategies for ADC and mAb Control

Novel Approach to ADA Assay Development to Overcome Target Interference Issues from Dimerization
Massbio-logo

Now Streaming On-Demand

Antibody-drug conjugates (ADCs) and monoclonal antibodies (mAbs) demand a diverse set of analytical tools to fully characterize their structure, function, and comparability. In this webinar, hosted by AAPS, expert CMC analytical scientists walk through real-world case studies demonstrating how advanced techniques, including LC/MS, CE, SPR, and other orthogonal assays, deliver deeper insight into product safety, efficacy, and mechanism of action.

Through practical, data-driven examples, the session highlights how integrating multiple analytical approaches strengthens decision-making across development and manufacturing. Viewers will gain actionable strategies to support robust control and streamline characterization workflows.

. 

Watch now to learn how to:

  • Apply LC/MS, CE, SPR, and complementary techniques to characterize ADCs and mAbs
  • Interpret orthogonal data outputs to understand structure–function relationships and assess comparability
  • Translate case-driven insights into stronger analytical strategies throughout product development and lifecycle management 
About the Speakers

Our experts will discuss lessons learned from their experiences and offer insight into the multiple stages of specific assays including critical reagents, regulatory standards, assay formats and timelines.

Speakers:
  • Jessica Weaver, MRes, Scientific Officer, BioAgilytix  
  • Daniel Worms, PhD, Scientific Operations, BioAgilytix
  • Bryan Thacker, PhD, Scientific Operations, BioAgilytix  
 
Comprehensive Analytical Strategies for ADC and mAb Control Thumbnail

Share this Resource

icon-twitter icon-linkedin link 1

Watch Now!

Complete the form to view the recording.